Table 3.
Logistic regression analysis of associations between respiratory viruses and clinical diagnosis
Virus | Upper respiratory tract infections (N = 2383) |
Croup (N = 141) |
Lower respiratory tract infections (N = 2356) |
|||
---|---|---|---|---|---|---|
n (%) | OR (95% CI) | n (%) | OR (95% CI) | n (%) | OR (95% CI) | |
RSVA | 64 (1.3%) | 0.16 (0.12–0.21) | 302 (6.2%) | 5.50 (4.20–7.20) | ||
RSVB | 46 (0.9%) | 0.11 (0.08–0.15) | 325 (6.7%) | 8.40 (6.19–11.40) | ||
FluA | 235 (4.8%) | 2.88 (2.15–3.86) | 58 (1.2%) | 0.31 (0.23–0.42) | ||
FluB | 120 (2.5%) | 4.89 (2.98–8.04) | 17 (0.3%) | 0.19 (0.11–0.32) | ||
PIV1 | 40 (0.8%) | 0.31 (0.21–0.46) | 30 (0.6%) | 17.20 (10.30–28.75) | ||
PIV2 | 8 (0.2%) | 22.22 (9.24–53.47) | ||||
PIV3 | 89 (1.8%) | 0.52 (0.39–0.69) | 21 (0.4%) | 5.34 (3.13–9.12) | 127 (2.6%) | 1.40 (1.06–1.85) |
PIV4 | 14 (0.3%) | 0.37 (0.19–0.72) | 28 (0.8%) | 2.38 (1.26–4.50) | ||
HMPV | 65 (1.3%) | 0.18 (0.14–0.24) | 264 (5.4%) | 5.43 (4.09–7.20) | ||
HRV/EV | 587 (12.0%) | 0.63 (0.55–0.73) | 712 (14.6%) | 1.54 (1.33–1.79) | ||
ADV | 603 (12.4%) | 3.41 (2.81–4.14) | 4 (0.1%) | 0.22 (0.08–0.61) | 164 (3.4%) | 0.31 (0.26–0.38) |
HCoV | 8 (0.2%) | 3.60 (1.67–7.73) | 50 (1.0%) | 0.63 (0.42–0.92) | ||
HBoV | 71 (1.5%) | 0.37 (0.28–0.50) | 175 (3.6%) | 2.70 (2.01–3.61) |
Only the variables with p < 0.05 were shown